We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
FDA批准了Casgevy——首个针对镰状细胞病和β-地中海贫血的CRISPR基因疗法。了解Vertex和CRISPR Therapeutics的突破如何改变生活。
